Ocul Immunol Inflamm. 2013;21(1):90-1. doi: 10.3109/09273948.2012.736589.
To report dislocation of dexamethasone implant (Ozurdex®) into the anterior chamber and to discuss intervention options.
Interventional case report.
An 89-year-old woman presented after Ozurdex® implant injection for chronic cystoid macular edema secondary to idiopathic intermediate uveitis. The dexamethasone implant dislocated into the anterior chamber. Pharmacologic dilation was administered and the patient was placed in a reclined supine position.
Successful repositioning of the implant into the vitreous cavity.
Although it is a rare complication, anterior dislocation of a dexamethasone implant may have serious consequences. Early recognition and appropriate management is advisable.
报告地塞米松植入物(Ozurdex®)脱位至前房,并讨论干预措施。
介入性病例报告。
一位 89 岁女性,因特发性中间葡萄膜炎继发慢性囊样黄斑水肿行 Ozurdex®植入物注射后就诊。地塞米松植入物脱位至前房。给予药物扩瞳并将患者置于仰卧斜位。
成功将植入物重新定位至玻璃体腔。
尽管这是一种罕见的并发症,但地塞米松植入物的前脱位可能会产生严重后果。早期识别和适当的处理是明智的。